Home | 2003 (1997-2003) Cover Shorty | Inside cover | News 11-04 | News 6-04 | Current stock holdings | Election results | Stock from the company | Stock givers /traders | Profit and loss | Balance sheet 2003 | Balance sheet 2000 | RE, S&U, bank stmts 2003 | RE, S&U, bank stmts 2000 | News & history first half 2004 | Dr. Peebles' story | News & history 2001 - 2003 | News & history 1997 - 2000 | Owners like Pfizer strategy | Wal-Mart strategy | Pedi-sales strategy | Celgene takeover of pediatric drugs strategy | Device maker strategy | Your choice for licensing strategies | Ballot | Expenses graph | Expense report 2003 | Goodwill report 2003 | Contacts
Prophy Research Corporation reports
RE, S&U, bank stmts 2003

Statement of Retained Earnings
Prophy Research Corporation
3-22-04 draft Years 2000-2003
(in dollars)
2003 2002 2001 2000
Balance of retained earnings -58,882 -58,773 -58,059 -60,849
or (loss) at year beginning
+ or - earnings or (loss) -1,967 -109 -714 -1,284
during year
Balance of retained earnings -60,849 -58,882 -58,773 -62,133
or (loss) at year end
                           
Sources and Uses of Funds
Sources of funds
Cash from stockholders 1,942 109 689 1,259
Cash decrease 25 0 25 25
Total sources 1,967 109 714 1,284
Uses of funds
Cash expenses 1,967 109 714 1,284
Cash increase 0 0 0 0
Total uses 1,967 109 714 1,284
                           
Bank Statement
Cash (Ray's pocket) 0 0 0 0
Bank (corporate account) 1,027 1,052 1,052 1,077
Total cash 1,027 1,052 1,052 1,077

On to the next page (older financial stmts)